ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,652Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 780

$920K Total Retail Price of All Prescriptions

Rank: 82 out of 780

685 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 685 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 685 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 15,492 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 691 609 1 3
LEVOTHYROXINE SODIUM 577 537 2 5
HYDROCODONE-ACETAMINOPHEN 576 404 S3 3 1
AMLODIPINE BESYLATE 532 475 4 4
SIMVASTATIN 444 349 5 2
POTASSIUM CHLORIDE 432 372 6 11
TRAMADOL HCL 415 336 7 15
FUROSEMIDE 410 341 8 7
ISOSORBIDE MONONITRATE ER 376 347 9 60
METFORMIN HCL 358 277 10 8
PRAVASTATIN SODIUM 353 317 11 9
LISINOPRIL 297 247 12 6
RANITIDINE HCL 293 241 13 39
ZOLPIDEM TARTRATE 292 208 14 17
PANTOPRAZOLE SODIUM 287 238 15 25
METOPROLOL SUCCINATE 269 230 16 20
LOSARTAN POTASSIUM 268 243 17 18
WARFARIN SODIUM 256 221 18 24
MELOXICAM 252 210 19 16
BUMETANIDE 248 195 20 96
AMITRIPTYLINE HCL 228 188 R 21 48
DONEPEZIL HCL 228 228 21 31
CLONIDINE HCL 228 184 21 28
METOPROLOL TARTRATE 221 163 24 19
GABAPENTIN 203 153 25 13
CITALOPRAM HBR 184 165 26 23
NAMENDA 175 175 27 46
ATORVASTATIN CALCIUM 174 162 28 12
DIGOXIN 168 161 29 56
HYDROCHLOROTHIAZIDE 163 125 30 10
CRESTOR 160 125 31 32
CLOPIDOGREL 155 141 32 34
MIRTAZAPINE 155 134 32 58
QUETIAPINE FUMARATE 151 114 34 81
CARVEDILOL 143 106 35 14
ATENOLOL 137 129 36 21
TRAZODONE HCL 127 78 37 35
NEXIUM 124 101 38 22
SPIRONOLACTONE 119 110 39 53
GLIMEPIRIDE 115 78 40 30
PLAVIX 114 103 41 45
SERTRALINE HCL 110 103 42 27
LEVOFLOXACIN 109 97 43 76
CYMBALTA 109 52 43 51
TAMSULOSIN HCL 105 105 45 36
KLOR-CON M20 104 92 46 57
PAROXETINE HCL 104 87 46 69
PREDNISONE 103 85 48 40
CYCLOBENZAPRINE HCL 101 70 R 49 42
FLUTICASONE PROPIONATE 100 68 50 41
LOSARTAN-HYDROCHLOROTHIAZIDE 97 81 51 33
RAMIPRIL 97 80 51 70
BYSTOLIC 95 83 53 118
AZITHROMYCIN 95 82 53 38
TERAZOSIN HCL 93 77 55 160
VERAPAMIL ER 91 91 56 78
CIPROFLOXACIN HCL 90 76 57 49
LYRICA 89 40 58 52
KLOR-CON 10 88 88 59 90
ALLOPURINOL 81 73 60 29
SPIRIVA 80 62 61 72
AMOXICILLIN 80 68 61 99
HUMULIN 70-30 80 53 61 106
NAPROXEN 78 66 64 100
AMLODIPINE BESYLATE-BENAZEPRIL 78 54 64 50
GLIPIZIDE 74 61 66 74
CELEBREX 74 72 66 89
NIFEDIPINE ER 72 49 68 115
SINGULAIR 71 61 69 73
CEPHALEXIN 69 59 70 105
TRIAMTERENE-HCTZ 65 59 71 37
CILOSTAZOL 65 45 71 229
MECLIZINE HCL 62 56 73 83
DILTIAZEM 24HR ER 62 62 73 179
DILTIAZEM 24HR CD 62 59 73 138
DOXYCYCLINE HYCLATE 60 54 76 103
ENALAPRIL MALEATE 60 46 76 64
HYDRALAZINE HCL 59 48 78 54
NOVOLIN 70-30 59 50 78 164
PREMARIN 59 43 R 78 110
INSULIN SYRINGE 59 43 78 80
NITROSTAT 59 47 78 244
ADVAIR DISKUS 58 48 83 68
RISPERIDONE 54 45 84 98
PRADAXA 54 54 84 255
FINASTERIDE 53 53 86 150
FLUOXETINE HCL 52 31 87 65
ONDANSETRON HCL 51 43 88 234
METHOCARBAMOL 50 29 R 89 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.